A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer
Clinical trial NCT03122509 · COMPLETED
Trial details
- NCT number
- NCT03122509
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2021-04-28
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.